Profil
Nabil A.
Abadir is currently the Global Chief Medical Officer & Senior VP at Amarin Corp.
Plc.
Prior to this role, he served as the Executive VP-Medical & Scientific Affairs at Clementia Pharmaceuticals, Inc.
Postes actifs de Nabil A. Abadir
| Sociétés | Poste | Début |
|---|---|---|
| AMARIN CORPORATION PLC | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Anciens postes connus de Nabil A. Abadir
| Sociétés | Poste | Fin |
|---|---|---|
| CLEMENTIA PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
